Print Friendly  |  
  • LinkedIn
  • Add to Favorites

 New International Clinical Practice Guidelines Debut

An international group of experts from 13 nations has published a new set of clinical practice guideline recommendations for the management of frailty. The recommendations highlight the need to provide evidence-based information to providers, to help providers better recognize and manage frailty, and to improve quality of life and outcomes for those living with reduced strength and function.

The new information appears in the July issue of JAMDA, the official journal of AMDA – The Society for Post-Acute and Long-Term Care Medicine, and is titled: “The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty.”
In technical terms, frailty is defined as “a reduced strength and physiologic malfunctioning that increases an individual’s susceptibility to increased dependency, vulnerability, and death,” and requires special clinical attention by providers, the report said. Within the research, the authors grouped their recommendations into strong, conditional, and no-recommendation categories.

Each category refers directly to the strength of its supporting evidence base, researchers said. The strong recommendations were for providers to use a validated measurement tool to identify frailty, to prescribe physical activity with a resistance training component, and to address polypharmacy by reducing or deprescribing any inappropriate/superfluous medications.

The conditional recommendations were to screen for, and address, modifiable causes of fatigue, to screen those persons showing unintentional weight loss for reversible causes and consider food fortification and protein caloric supplementation, and, lastly, to prescribe vitamin D for individuals displaying such a deficiency.
The JAMDA report said no recommendation was given regarding the provision of a patient support and education plan.

Access the report at
Facebook.png   Twitter   Linked-In   ProviderTV   Subscribe

Sign In